ZIRESOVIR

UNII:	XCF42D7AG4
Type:	INGREDIENT SUBSTANCE
Formula:	C₂₂H₂₅N₅O₃S
Preferred Substance Name:	ZIRESOVIR
InChIKey:	GAAICKUTDBZCMT-UHFFFAOYSA-N
GSRS Full Record:	XCF42D7AG4 i

1422500-60-4
4-(4-(((3-AMINOOXETAN-3-YL)METHYL)AMINO)-6-METHYLQUINAZOLIN-2-YL)-2,3,4,5-TETRAHYDRO-1H-1.LAMBDA.6,4-BENZOTHIAZEPINE-1,1-DIONE
4-QUINAZOLINAMINE, N-((3-AMINO-3-OXETANYL)METHYL)-2-(2,3-DIHYDRO-1,1-DIOXIDO-1,4-BENZOTHIAZEPIN-4(5H)-YL)-6-METHYL-
AK-0529
AK0529
N-((3-AMINO-3-OXETANYL)METHYL)-2-(2,3-DIHYDRO-1,1-DIOXIDO-1,4-BENZOTHIAZEPIN-4(5H)-YL)-6-METHYL-4-QUINAZOLINAMINE
N-((3-AMINOOXETAN-3-YL)METHYL)-2-(1,1-DIOXIDO-2,3-DIHYDRO-1,4-BENZOTHIAZEPIN-4(5H)-YL)-6-METHYLQUINAZOLIN-4-AMINE
N-[(3-aminooxetan-3-yl)methyl]-2-(1,1-dioxo-3,5-dihydro-2H-1lambda6,4-benzothiazepin-4-yl)-6-methylquinazolin-4-amine
RO-0529
Ziresovir [WHO-DD]
ziresovir [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

ZIRESOVIR

Synonyms and Mappings

Resources